# Inhalers and Bronchodilator Pharmacology

> Inhalers and bronchodilator pharmacology for NEET-PG Medicine: SABA, LABA, LAMA and ICS mechanisms, device choice, combinations and adverse effects in practice.

- Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/inhalers-and-bronchodilator-pharmacology
- Exam / course: NEET-PG · Subject: Medicine
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-08
- Last updated: 2026-10-08
- Reference basis: Harrison's Principles of Internal Medicine; Goodman and Gilman's The Pharmacological Basis of Therapeutics; GINA Global Strategy for Asthma Management and Prevention
- How to cite: "Inhalers and Bronchodilator Pharmacology", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/inhalers-and-bronchodilator-pharmacology

## Direct answer

Inhalers and bronchodilator pharmacology centres on four drug classes: short- and long-acting beta-2 agonists relax airway smooth muscle, long-acting muscarinic antagonists block vagal bronchoconstriction, and inhaled corticosteroids suppress eosinophilic airway inflammation. Choice of molecule matters less than choice of device, because a dry powder inhaler needs enough inspiratory flow to deliver the dose, while a metered-dose inhaler needs coordination or a spacer. In asthma a long-acting beta-2 agonist must never be used without an inhaled corticosteroid, and that rule is the single most examined point.

## What you must remember

- **SABA:** salbutamol and terbutaline act within minutes as reliever drugs; tremor and tachycardia are common, and rising use signals poor control.
- **LABA:** salmeterol and formoterol give twelve-hour or longer effect; in asthma they are combined with an ICS, while in COPD they are combined with a LAMA.
- **LAMA:** tiotropium is a mainstay of COPD maintenance and is not used as monotherapy in asthma; dry mouth and urinary retention are typical adverse effects.
- **ICS:** beclometasone, budesonide and fluticasone reduce exacerbations; oropharyngeal candidiasis and dysphonia are the commonest effects, reduced by rinsing the mouth.
- **Ipratropium:** a short-acting muscarinic antagonist used in acute severe asthma and COPD exacerbations, distinct from long-acting tiotropium.
- **Device technique:** dry powder devices need a rapid, strong inhalation, while pressurised inhalers with a spacer suit children and acute attacks.
- **Safety:** non-selective beta blockers such as propranolol can precipitate bronchospasm, whereas cardioselective agents are generally tolerated in stable asthma.

## A stepwise plan for a patient with asthma

A 34-year-old woman uses salbutamol four times a week and wakes at night with wheeze.

1. **Check technique and adherence:** Guideline-based care starts by checking her inhaler technique and adherence before escalating anything.
2. **Start ICS with formoterol:** A low-dose ICS with formoterol, used both as maintenance and reliever, is a reasonable step because it reduces exacerbations more effectively than an as-needed beta-2 agonist alone.
3. **Escalate if control is poor:** The ICS dose can be increased or a LAMA added, and the patient is reviewed for triggers such as allergy or reflux.
4. **Re-label if COPD emerges:** If she later develops persistent airflow obstruction in middle age with a smoking history, the picture shifts to COPD, with the emphasis on a LAMA and LABA added only when breathlessness or exacerbations persist.
5. **Match the device to the diagnosis:** The same molecules are used in both conditions, but the sequence of combination and the device must be matched to the diagnosis.
6. **Use spacers:** Spacers are recommended for metered-dose inhalers in children and during acute attacks, because they reduce the coordination needed and deposit more drug in the airways.

In Indian practice, the National List of Essential Medicines includes salbutamol and beclometasone inhalers, so these are the affordable first-line choices in public facilities.

## Where the exam tries to catch you

The most damaging errors involve combinations, look-alike drugs and beta blockers.

- **Trap:** choosing a LABA as monotherapy for asthma — **Correct:** LABA use without an ICS is linked to asthma-related deaths, so the correct answer is always an ICS plus LABA combination.
- **Trap:** confusing ipratropium with tiotropium — **Correct:** ipratropium is a short-acting drug for acute bronchospasm, while tiotropium is a once-daily maintenance drug for COPD.
- **Trap:** prescribing a beta blocker to an asthmatic with hypertension without checking selectivity — **Correct:** non-selective agents are contraindicated, while cardioselective ones are relatively safe.
- **Trap:** assuming every asthma inhaler is for relief only — **Correct:** budesonide with formoterol can serve both as maintenance and reliever, which exam questions present as a newer approach.

## Frequently asked questions

### Why must a long-acting beta-2 agonist never be used alone in asthma?

Long-acting beta-2 agonists used without an inhaled corticosteroid in asthma have been associated with asthma-related deaths. In asthma, a LABA must always be combined with an ICS, while in COPD it is commonly combined with a LAMA.

### Which bronchodilator is the mainstay of COPD maintenance therapy?

Long-acting muscarinic antagonists such as tiotropium are the mainstay of COPD maintenance therapy, because they reduce bronchoconstriction with once-daily dosing. Escalation to a LABA plus LAMA is used when breathlessness or exacerbations persist.

### What adverse effect is most associated with inhaled corticosteroids?

Oropharyngeal candidiasis and dysphonia are the commonest adverse effects of inhaled corticosteroids. Rinsing the mouth after use reduces them, and a spacer lowers oropharyngeal deposition of the drug.

### Which beta blocker is safer in patients with asthma?

Cardioselective beta-1 blockers such as metoprolol or bisoprolol are generally tolerated in stable asthma, whereas non-selective agents like propranolol can precipitate bronchospasm. Cardioselectivity is relative rather than absolute, so caution is still advised.